Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Bayside Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00163683
First received: September 11, 2005
Last updated: November 15, 2005
Last verified: September 2005
  Purpose

In this study we will compare the effects of a Mediterranean diet, high in fruit and vegetables with the more conventional diet recommended for diabetes therapy (a high carbohydrate, low fat diet) on glycaemic and lipid control and on markers of inflammation, in people with newly diagnosed Type 2 diabetes. The hypothesis is that, over a six-month intervention period, a HVM diet will be more effective than a conventional HCLF diet in improving glycaemic and lipid control, and in reducing markers of vascular inflammation in people with Type 2 diabetes.


Condition Intervention
Type 2 Diabetes
Coronary Heart Disease
Behavioral: Dietary Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: The Effect of a Mediterranean Style Diet Versus a Conventional High Carbohydrate, Low Fat Diet on Glycaemic and Lipid Control and on Vascular Inflammatory Markers in People With Newly Diagnosed Type 2 Diabetes

Resource links provided by NLM:


Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • The primary outcomes include: HBAIc and lipids (Cholesterol, HDL-cholesterol, Triglycerides) at study entry and 6 months after dietary intervention

Secondary Outcome Measures:
  • Key secondary outcomes include: TNF-a, IL-6, High sensitivity CRP, plasma carotenoids and serum fatty acids.

Estimated Enrollment: 24
Study Start Date: January 2003
Detailed Description:

Chronic inflammation affecting both small and large blood vessels is an important factor increasing the risk of heart disease in people with Type 2 diabetes. Good markers present in the blood are now available to detect this inflammatory state. Recent evidence suggests that a Mediterranean-type diet, high in plant foods and with monounsaturated fat from olive oil has beneficial effects on blood vessels as well as on blood glucose and blood lipid control.

In this study we will compare the effects of a Mediterranean diet, high in fruit and vegetables with the more conventional diet recommended for diabetes therapy (a high carbohydrate, low fat diet). Twenty-four people with Type 2 diabetes will be randomised to one of these diets and followed for six months. At the end of this time, the effect of the diets on markers for inflammation will be compared.

  Eligibility

Ages Eligible for Study:   30 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

-English speaking people with newly diagnosed Type 2 diabetes (within 3-12 months of diagnosis) who are attending the Alfred Hospital, Diabetes Education Outpatient Clinic.

Exclusion Criteria:

  • age <30 years or > 75 years;
  • body mass index (BMI) < 25 kg/m2 or >37 kg/m2;
  • on corticosteroid or insulin therapy;
  • presence of established renal and/or liver disease (serum creatinine more than 0.12 mmol/L/albumin excretion rate greater than 300 µg per minute or ALT more than twice the upper limit of normal respectively).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00163683

Contacts
Contact: Rachel M Stoney, PhD +613 9276 3063 r.stoney@alfred.org.au
Contact: Karen Walker, PhD +613 9594 4472 karen.walker@med.monash.edu.au

Locations
Australia, Victoria
Alfred Hospital Recruiting
Melbourne, Victoria, Australia, 3181
Contact: Rachel M Stoney, PhD     +61 3 9276 3063     r.stoney@alfred.org.au    
Contact: Karen Z Walker, PhD     +61 3 95944472     karen.walker@med.monash.edu.au    
Principal Investigator: Rachel M Stoney, PhD            
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: Rachel M Stoney, PhD Alfred Hospital, Melbourne, AUSTRALIA
Study Director: Karen Z Walker, PhD Monash University, Melbourne, AUSTRALIA
Study Director: Duncan Topliss, FRACP Alfred Hospital, Melbourne, AUSTRALIA
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00163683     History of Changes
Other Study ID Numbers: A33420
Study First Received: September 11, 2005
Last Updated: November 15, 2005
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by Bayside Health:
Dietary Intervention

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Diabetes Mellitus
Diabetes Mellitus, Type 2
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 21, 2013